Celgene profit rises 25 pct up on higher cancer drug sales By: Reuters: Company News July 24, 2014 at 07:50 AM EDT July 24 (Reuters) - Celgene Corp reported a 25 percent increase in quarterly profit, helped by robust sales of its flagship cancer drug, Revlimid. Read More >>